Journal Article10.1016/J.DIABRES.2007.06.007
Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study §,§§
51
TL;DR: A minority of community-based type 1 patients had the metabolic syndrome and its presence did not add significant prognostic predictive value to conventional vascular risk factors, as well as being a significant predictor of cardiac mortality.
read more
About: This article is published in Diabetes Research and Clinical Practice. The article was published on 01 Dec 2007. The article focuses on the topics: Metabolic syndrome & Type 1 diabetes.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.
Salvatore Mottillo,Kristian B. Filion,Jacques Genest,Lawrence Joseph,Louise Pilote,Paul Poirier,Stéphane Rinfret,Ernesto L. Schiffrin,Mark J. Eisenberg +8 more
TL;DR: A systematic review and meta-analysis of the cardiovascular risk associated with the metabolic syndrome as defined by the 2001 NCEP and 2004 revised National Cholesterol Education Program definitions found the syndrome is associated with a 2-fold increase in cardiovascular outcomes and a 1.5- fold increase in all-cause mortality.
2.8K
Type 1 diabetes, metabolic syndrome and cardiovascular risk
TL;DR: New therapeutic strategies are required in T1DM subjects, not only to intensively lower glycemia, but to control all associated metabolic syndrome traits.
189
Chronic complications and mortality in community‐based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study
TL;DR: To compare the prevalence and incidence of chronic complications and cardiac and all‐cause mortality in community‐based patients with latent autoimmune diabetes in adults (LADA) with those in Type 2 diabetic patients without antibodies to glutamic acid decarboxylase (GAD).
60
Metabolic syndrome in type 1 diabetes
TL;DR: It is shown that metabolic syndrome is associated with a higher incidence of diabetes-related complications, a need for higher insulin doses and a more aggressive multifactorial intervention.
42
Predictors of cardiovascular risk among patients with type 1 diabetes: A critical analysis of the metabolic syndrome and its components.
TL;DR: In this paper, the applicability and limitations of the metabolic syndrome in patients with Type 1 diabetes were reviewed and alternative avenues to identify high-risk patients were discussed, and the authors concluded that the current definition of MetS may not be the most suitable tool.
42
References
Diagnosis and Management of the Metabolic Syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Scott M. Grundy,James I. Cleeman,Stephen R. Daniels,Karen A. Donato,Robert H. Eckel,Barry A. Franklin,David Gordon,Ronald M. Krauss,Peter J. Savage,Sidney C. Smith,John A. Spertus,Fernando Costa +11 more
TL;DR: This statement from the American Heart Association and the National Heart, Lung, and Blood Institute is intended to provide up-to-date guidance for professionals on the diagnosis and management of the metabolic syndrome in adults.
11.2K
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Bo Isomaa,Peter Almgren,Tiinamaija Tuomi,Björn Forsén,Kaj Lahti,Michael Nissén,Marja-Riitta Taskinen,Leif Groop +7 more
TL;DR: The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from diferent studies.
5.2K
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M. Nathan,Patricia A. Cleary,Jye Yu C. Backlund,Saul Genuth,John M. Lachin,Trevor J. Orchard,Philip Raskin,Bernard Zinman +7 more
TL;DR: Intensive diabetes therapy has long-term beneficial effects on the risk of cardiovascular disease in patients with type 1 diabetes, and changes between treatment groups remained significant after adjusting for these factors.
The Metabolic Syndrome: Time for a Critical Appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
TL;DR: Until much needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the "metabolic syndrome."